03902nam 22005175 450 991025446500332120200706082242.03-319-51673-610.1007/978-3-319-51673-8(CKB)3710000001124871(DE-He213)978-3-319-51673-8(MiAaPQ)EBC4831867(PPN)199769885(EXLCZ)99371000000112487120170327d2017 u| 0engurnn#008mamaatxtrdacontentcrdamediacrrdacarrierPharmaceutical Policy in Countries with Developing Healthcare Systems /edited by Zaheer-Ud-Din Babar1st ed. 2017.Cham :Springer International Publishing :Imprint: Adis,2017.1 online resource (XII, 430 p. 36 illus., 33 illus. in color.)3-319-51672-8 Includes bibliographical references at the end of each chapters.1. Introduction -- Section I: Low and Lower Middle Income Countries -- 2. Pharmaceutical Policy in the East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania -- 3. Pharmaceutical Policy in Pakistan -- 4. Pharmaceutical Policy in Philippines -- 5. Pharmaceutical Policy in Vietnam -- Section II: Upper Middle Income Countries -- 6. Pharmaceutical Policy in Argentina -- 7. Pharmaceutical Policy in Brazil -- 8. Pharmaceutical Policy In Bulgaria -- 9. Pharmaceutical Policy in China -- 10. Pharmaceutical Policy in Colombia -- 11. Pharmaceutical Policy in Ecuador -- 12. Pharmaceutical Policy in Jordan -- 13. Pharmaceutical Policy in Russia -- 14. Pharmaceutical Policy in South Africa -- Section III: High Income Countries -- 15. Pharmaceutical Policy in Poland -- 16. Pharmaceutical Policy in Saudi Arabia -- 17. Pharmaceutical Policy in Trinidad and Tobago -- 18. Pharmaceutical Policy in United Arab Emirates -- Section IV: Further Perspectives -- 19. ‘Repurposing’ Medicines: a Case for Low- and Middle-Income Countries with Developing Healthcare Systems -- 20. Pharmaceutical Policy in Countries with Developing Healthcare Systems: Synthesis of Country Case Studies.A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.PharmacyPublic healthPharmacyhttps://scigraph.springernature.com/ontologies/product-market-codes/F00008Public Healthhttps://scigraph.springernature.com/ontologies/product-market-codes/H27002Science, Humanities and Social Sciences, multidisciplinaryhttps://scigraph.springernature.com/ontologies/product-market-codes/A11007Pharmacy.Public health.Pharmacy.Public Health.Science, Humanities and Social Sciences, multidisciplinary.338.45362.1782615.1Babar Zaheer-Ud-Dinedthttp://id.loc.gov/vocabulary/relators/edtBOOK9910254465003321Pharmaceutical Policy in Countries with Developing Healthcare Systems2513554UNINA